NEW YORK – Which articles gained the most interest from GenomeWeb readers last week? Here are the top five:
- Illumina to Pay $333.8M in Damages Following Jury Verdict in MGI Tech Patent Infringement Suit
- FDA Classifies Mesa Biotech Recall of Accula SARS-CoV-2 Tests as Class I
- Guardant Health Confident in New CRC Screening Blood Test Despite Competitor Skepticism
- Siemens Healthineers Set to Develop Next-Generation, High-Throughput MDx Platform
- 10x Genomics Sues NanoString Technologies, Vizgen Over Spatial Gene Expression Analysis Technologies